Skip to main content

Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences?

Publication ,  Conference
Le, H; Ryan, K; Wahlstrom, SK; Pendergraft, T; Maculaitis, MC; Will, O; Mulvihill, E; LeBlanc, TW
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

29

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Le, H., Ryan, K., Wahlstrom, S. K., Pendergraft, T., Maculaitis, M. C., Will, O., … LeBlanc, T. W. (2020). Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Le, Hannah, Kellie Ryan, Svea K. Wahlstrom, Trudy Pendergraft, Martine C. Maculaitis, Oliver Will, Emily Mulvihill, and Thomas William LeBlanc. “Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences?” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Le H, Ryan K, Wahlstrom SK, Pendergraft T, Maculaitis MC, Will O, et al. Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Le H, Ryan K, Wahlstrom SK, Pendergraft T, Maculaitis MC, Will O, Mulvihill E, LeBlanc TW. Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? JOURNAL OF CLINICAL ONCOLOGY. 2020.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

29

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences